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Abstract
Background: Despite infections by the dengue virus being a significant problem in tropical and
sub-tropical countries, the mechanism by which the dengue virus enters into mammalian cells
remains poorly described.
Methods: A combination of biochemical inhibition, dominant negative transfection of Eps15 and
siRNA mediated gene silencing was used to explore the entry mechanism of dengue into HepG2
cells.
Results: Results were consistent with entry via multiple pathways, specifically via clathrin coated
pit mediated endocytosis and macropinocytosis, with clathrin mediated endocytosis being the
predominant pathway.
Conclusion: We propose that entry of the dengue virus to mammalian cells can occur by multiple
pathways, and this opens the possibility of the virus being directed to multiple cellular
compartments. This would have significant implications in understanding the interaction of the
dengue virus with the host cell machinery.
Background
While most animal viruses enter into cells by receptor
mediated endocytosis in clathrin coated pits [1,2], evi-
dence to date suggests that the normal mechanism of den-
gue virus entry into both insect and mammalian cells is by
direct fusion of the virus with the cell membrane [3-6],
although endocytosis of dengue viruses has been observed
with neutralization escape mutants [5], in the presence of
neutralizing antibodies [6] as well as in the non-target cell
line Hela [7]. These results are somewhat contradictory to
results with other flaviviruses, and both Japanese
encephalitis virus (JEV) and West Nile virus have been
shown to enter cells via clathrin coated pits [8-10]. How-
ever, the majority of the studies undertaken to date on the
dengue viruses have been based upon electron micros-
copy ultrastructural studies [4-6] or non-target cells [7]
and as such no comprehensive direct biochemical or
genetic analysis of the entry mechanism of the dengue
virus has yet been undertaken.
Methods
Cells and viruses
HepG2 and Vero cells were maintained as previously
described [11-13] Dengue serotypes 1 (strain 16007), 2
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(strain 16681), 3 (strain 16562) and 4 (strain 1036) were
propagated in Vero cells and purified as described previ-
ously [11,12].
Cytotoxicity assessment by Annexin V staining
Confluent HepG2 cells were pretreated at 37°C with
either 20 M cytochalasin D or 30 g/ml nystatin for 2 hr,
or with 15 g/ml chlorpromazine or 3 mM amiloride or
50 M LY294002 or 0.2 M wortmannin for 1.5 hr with
80% DMSO for 20 hours as a positive control. Cells were
then trysinized and subsequently washed twice with cold-
PBS. Cells were then washed with binding buffer (BD Bio-
sciences Pharmingen, San Diego, CA) and resuspended in
binding buffer. Annexin V-FITC (BD Biosciences
Pharmingen, San Diego, CA) was added to the cell sus-
pensions and samples were incubated in the dark for 15
min before analysis by flow cytometry (BD FACSCalibur
# E6361).
Biochemical inhibition of dengue entry
Confluent HepG2 cells were pretreated at 37°C with chlo-
rpromazine, amiloride, wortmannin or LY294002 for 30
min or with cytochalasin D or nystatin for 1 hr. The cells
were infected with each dengue serotype in either in the
presence or absence of the appropriate inhibitor at an
MOI of 1, for 1 hr at 37°C. The extracellular viruses were
then inactivated by acid glycine (pH3) treatment [14]. The
infected cells were further grown for one propagation
cycle minus two hours with the exact time dependent
upon the dengue serotype as determined previously [12],
and the number of infected cells determined by our adap-
tation of the standard plaque assay [15]. Experiments
were undertaken independently in triplicate with dupli-
cate plaque assay of samples.
Eps15 transfection, infection and indirect 
immunofluorescence microscopy
Plasmid constructs of dominant negative (DIII and EH29)
and control (D32) Eps15 were kindly provided by A.
Benmerah (Department of Infectious Diseases, Institut
Cochin, Paris, France). Transfections of HepG2 cells were
undertaken using lipofectamine2000 (Invitrogen, OR.,
USA). Briefly, 3 g of the appropriate plasmid DNA was
complexed with 4 l of lipofectamine2000 for 30 min at
room temperature and then added to HepG2 cells pre-
grown to 70–80% confluency on glass coverslips. The cell/
complex mix was incubated at 37°C, 10% CO2 for 2 days.
Transfection efficiencies routinely exceeded 70% effi-
ciency as determined by counting of multiple fields.
Transfected cells were subsequently infected with dengue
virus serotype 1, 2, 3 or 4 at an MOI of 20 for 1.5 hr fol-
lowed by acid glycine (pH3) treatment to inactivate un-
internalized viruses [14] and incubated for 15 hr at 37°C,
10% CO2. A further set of cells were serum starved for 30
min and incubated with 5 g transferrin conjugated with
Alexa 594 (Molecular Probes, OR) at 37°C for 30 min fol-
low by acid glycine treatment.
Both dengue infected and transferrin treated transfected
cells were fixed with 4% paraformaldehyde for 30 min at
room temperature. Transferrin control cells were directly
mounted with Vectashield (Vector Laboratories, Inc., CA)
while dengue virus infected cells were further permeabi-
lized with 0.3% TritonX-100 and methanol. Nonspecific
binding was blocked by incubation with 5% BSA for 1 hr
at room temperature. Cells were incubated with an anti-
dengue E protein monoclonal antibody, HB-114 [16] at
4°C overnight. After six washes with 0.03% TritonX-100
in PBS cells were incubated with a chicken anti-mouse IgG
conjugated with Alexa 594 (Molecular Probes, OR) for 1
hr at room temperature and subsequently washed with six
washes of 0.03% TritonX-100 in PBS before mounting
with Vectashield (Vector Laboratories, Inc., CA).
siRNA design and generation
Target sites on clathrin heavy chain (GenBank accession
number NM_004859) and the green fluorescent protein
(GFP; GenBank accession number U50974) were deter-
mined using the on-line tool from Ambion, Austin, TX
http://www.ambion.com/techlib/misc/
siRNA_finder.html and the selected sequences were sub-
jected to siRNA template design to generate DNA oligonu-
cleotide sequences for use with the Silencer™ siRNA
Construction kit (Ambion). Six templates for siRNA gen-
eration were selected:
siCHC1: 298-AACCCAGCAACATTGGCTTC-318
siCHC2: 411-AAGTAATCCAATTCGAAGACC-431
siCHC3: 484-AAAGCTGGGAAAACTCTTCAG-504
siCHC4: 1951-AATAATCGCCCATCTGAAGGT-1971
siCHC5:3544-AATGAACCTGCGGTCTGGAGT-3564
siGFP: 295-AAAGATGACGGGAACTACAAG-315
Numbering indicates the corresponding position of the
selected 21 nucleotide sequence in the open reading
frame of NM_004859 (siCHC1 to siCHC5) or U50974
(siGFP). All sequences were searched against the NCBI's
database to confirm specificity. Sense and antisense DNA
templates were chemically synthesized (BioBasic, Can-
ada) and following the kit instructions based on in-vitro
transcription, the siRNAs were produced and quantified
by spectrophotometry.Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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siRNA transfection
HepG2 cells were maintained in Dulbecco's modified
Eagle's medium (DMEM) supplemented with 10% heat-
inactivated fetal bovine serum without antibiotics.
Reverse transfections according to the manufacturers pro-
tocols were performed with Lipofectamine™RNAiMAX
(Invitrogen, Carlsbad, CA) by mixing the respective siRNA
and 1.2 l of Lipofectamine™RNAiMAX and adding to a
single well of a 24 well plate. After 20 minutes of incuba-
tion at room temperature, a suspension of 5 × 104 HepG2
cells was added and cell: complex mixtures incubated
under standard conditions. Mock transfections (lipo-
fectamine only) were performed in parallel. All transfec-
tions were undertaken in a final volume of 600 l with
siRNA at a final concentration at 50 nM. Transfections
were harvested at 1 to 4 days post-transfection.
RNA extraction and RT-PCR analysis
Transfected cells from a single well of a 24-well plate were
homogenized in 0.5 ml Trizol reagent (Molecular
Research Center, Cincinnati, OH) and RNA purified as
recommended by the manufacturer. For the RT-PCR anal-
ysis, an oligo(dT)17 primer was used to synthesize first
strand cDNA using ImpromII™ reverse transcriptase
(Promega, Madison, WI). The cDNA was then amplified
in a multiplex reaction with 2 specific primer pairs for
CHC (CHCf: 5'-AAGCTCATCTTTGGGCAGAA-3'; CHCr:
5-GAGACAGCACCATCAGCAAA-3') and GAPDH (GAP-
DHf: TTGGTATCGTGGAAGGACTCA-3'; GAPDHr: 5'-
ACCACCTGGTGCTCAGTGTAG-3') as an internal con-
trol. Expected products were 343 bp (GAPDH) and 222
bp (CHC) Cycle conditions were 94°C for 3 minutes fol-
lowed by 20 cycles of 94°C for 30 seconds, 58°C for 45
seconds and 72°C for 45 seconds followed by a final
extension of 72°C for 7 minutes. PCR products were ana-
lyzed on 1.8% agarose gels containing ethidium bromide.
Infection of siRNA silenced HepG2 cells
HepG2 cells (5 × 104) were grown on coverslips in single
wells of a 24 well plate and transfected as above with
either siRNAs as stated or mock transfected. At day 3 post
transfection cells were infected with dengue virus serotype
2 MOI 20 for 2 hours followed by an acid glycine wash
and subsequently incubated for 15 hours under standard
conditions. Dengue virus E protein was detected as
described above except that cells were also stained with
DAPI. Parallel non-infected samples were incubated with
transferrin as described above and were additionally
stained with DAPI. Where biochemical inhibition was
used in conjunction with siRNA silencing, samples were
treated with 0.2 M wortmannin for 30 minutes immedi-
ately preceding dengue virus infection.
Results
Effect of endocytosis inhibitors on dengue virus entry
To investigate the mechanism of dengue virus internaliza-
tion into HepG2 cells, cells were pre-treated with cytoch-
alasin D, amiloride, LY294002 or wortmannin to inhibit
macropinocytosis, nystatin to inhibit caveolae mediated
entry or chlorpromazine to inhibit clathrin-coated pit
mediated. Prior to the infection experiment cells were
incubated with a range of concentrations of the inhibitors
to assess cytotoxicity. Cytotoxicity was initially assessed by
cellular morphological changes under light microscopy
(data not shown). Working concentrations (the highest
concentration without apparent cytotoxicity) were estab-
lished as: cytochalasin D at 20 M, amiloride at 3 mM,
LY294002 at 50 M, wortmannin at 0.2 M, nystatin 20
M at 30 M and chlorpromazine at 15 M (HepG2). The
lack of cytotoxicity at these concentrations was confirmed
by Annexin V staining and flow cytometry (Figure 1).
To determine the effects of the various inhibitors on den-
gue virus entry, cells were pre-incubated for 1 hr with cyto-
chalasin D or nystatin and for 30 min with
chlorpromazine, amiloride, wortmannin or LY294002 at
the concentrations determined above, following which
the cells were incubated separately with all four dengue
virus serotypes individually at an MOI of 1 for 1 hr follow-
ing which the virus: cell mixtures were treated with acid
glycine pH3 to inactivate any uninternalized viruses [14].
Cells were incubated under optimal growth conditions for
a time equivalent to one virus replication cycle minus 2 hr
based on our previous data for each serotype in HepG2
cells [12] following which the cells were briefly
trypsinized, serially diluted and plated onto pre-grown
cell monolayers and overlaid with agarose/nutrient
medium as previously described for this adaptation of the
standard plaque assay [15]. All experiments were under-
taken independently in triplicate with duplicate assay of
infected cell number.
Results (Figure 2) show that inhibition of caveolae medi-
ated endocytosis with nystatin results in a relatively uni-
form increase in the number of dengue virus infected cells
for all serotypes, while inhibition of clathrin coated pit
mediated endocytosis with chlorpromazine results in a
significant reduction in the number of dengue infected
cells for all four serotypes although the magnitude of the
effect is variable. Inhibition of macropinocytosis with
cytochalasin D, amiloride, LY294002 or wortmannin
showed a broad range of effects depending upon the spe-
cific inhibitor used, as well as to some extent the serotype
of the dengue virus (Figure 2).
Given that this study as well as our previous studies inves-
tigating dengue virus entry into HepG2 cells [11-
13,15,17-20] have routinely employed acid glycineJournal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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washes [14] to inactivate uninternalized viruses, we
sought to determine whether this would materially affect
the inhibition studies. The effect of acid glycine treatment
was assessed by pre-incubating HepG2 cells with one the
inhibitors (15 M chlorpromazine) or with medium
alone as a control. Cells were then infected with dengue
virus serotype 2 at MOI of 1 in presence or absence of the
inhibitor following which cells were either treated with
acid glycine (pH3) or subjected to three washes with PBS.
Numbers of infected cells were determined by our adapta-
tion of standard plaque assay [15]. Results showed that
washes with acid glycine did not increase virus entry due
to promoting viral fusion at the cell surface (Figure 3).
Dominant negative inhibition of clathrin coated pit 
endocytosis
Given that biochemical inhibitors can cause broad spec-
trum effects, we further sought to specifically knock out
clathrin-dependent endocytosis using over-expressing
dominant negative mutants of Eps-15 [21-23] which are
able to effectively inhibit clathrin-mediated endoctyosis
without affecting non-clathrin pathways [24]. HepG2
cells were transfected with either control (D32) or dom-
inant negative mutants (DIII and EH29) of the Eps15 pro-
tein fused to GFP as well as the vector containing GFP
only. Transfection with Lipofectamine2000 routinely
resulted in transfection efficiencies of greater than 70%
(data not shown). Transfected cultures were either
infected with each of the four dengue virus serotype indi-
Cytotoxicity assessement of biochemical inhibitors Figure 1
Cytotoxicity assessement of biochemical inhibitors. Flow cytometry histograms of HepG2 cells treated with working 
concentrations of cytochalasin D (C); amiloride (A); nystatin (N); chlorpromazine (Ch) LY294002 (L); wortmannin (W) or 
treated with 80% DMSO (+) or untreated (-).Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
Page 5 of 13
(page number not for citation purposes)
vidually at MOI of 20, or incubated with Alexa 594 conju-
gated-transferrin before incubation and fixation.
Visualization of signal was undertaken by incubating den-
gue infected samples with a primary monoclonal anti-
body directed against dengue E protein followed by
incubation with a chicken anti-mouse IgG conjugated
with Alexa 594.
Results show that both dominant negative Eps15 mutants
(DIII and EH29) significantly excluded the entry of trans-
ferrin (Figure 4). However, while the two mutants pre-
dominantly excluded entry of all four dengue serotypes
(Figure 4), numerous examples of dengue virus entry in
the presence of expression of the dominant negative
mutants were observed (Figure 5). Quantitation by count-
ing multiple fields (n > 30) suggested that 15- to 20% of
cells expressing either of the mutants were positive for
dengue virus entry for each serotype. In contrast, only
scattered cells were seen to be potentially positive for
transferrin entry in the presence of the mutants, and these
were possibly due to cells overlaying each other.
Effects of biochemical inhibitors of endocytosis on dengue virus entry Figure 2
Effects of biochemical inhibitors of endocytosis on dengue virus entry. HepG2 cells were pre-incubated with cytoch-
alasin D (C); amiloride (A); nystatin (N); chlorpromazine (Ch) LY294002 (L); wortmannin (W) or not pre-incubated (+) and 
subsequently infected with each serotype of the dengue viruses in the presence or absence of the respective treatment. Results 
are shown as a percentage of infected cells compared to control (100%). Error bar represent SEM of three independent exper-
iments assayed in duplicate.
Effect of acid glycine wash Figure 3
Effect of acid glycine wash. HepG2 cells were infected in 
the presence or absence of chlorpromazine (Ch) with our 
without an acid glycine wash. Results are shown as number of 
infected cells. Error bars represent SEM of three independent 
experiments assayed in duplicate.Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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siRNA mediated inhibition of clathrin heavy chain 
expression
Given the significant entry of the dengue virus in the pres-
ence of over-expressing dominant negative mutants of
Eps15, it is possible that either entry was occurring via
multiple pathways, or the Eps15 mutants were not com-
pletely inhibiting clathrin mediated entry. To further
explore this, RNA interference was used to down regulate
the expression of clathrin heavy chain, an integral part of
the clathrin vesicle [25]. Five different siRNAs (siCHCs)
against human clathrin heavy chain (GenBank accession
number NM_004859) were generated using in vitro tran-
scription together with 1 siRNA targeted to the green fluo-
rescent protein (GFP; GenBank accession number
U50974) for use as a control. To confirm all siRNAs were
double-stranded, an aliquot of each siRNA was treated
with RNaseIII which digests double-stranded RNA or
RNaseA which digests single-stranded RNA. All siRNA
constructs were confirmed to be off the appropriate size
and to consist of dsRNA (data not shown).
To optimize the silencing of the expression of the clathrin
heavy chain, the 5 different siCHCs were transfected into
HepG2 cells in parallel with transfections of siGFP and
lipofectamine alone (mock). On days 1 to 4 days post-
transfection, cells were harvested and RNA extracted. Mul-
tiplex RT-PCR was undertaken to detect messages from
GAPDH and clathrin heavy chain (CHC) simultaneously
Immunofluorescence of dengue infection and dominant negative mutant of Eps15 Figure 4
Immunofluorescence of dengue infection and dominant negative mutant of Eps15. HepG2 cell were transfected 
with either of two dominant negative Eps15 mutants (DIII or EH29) or a wild type Eps15 clone (D32) all fused to GFP or 
pEGFP as control, followed by infection with each dengue virus serotype individually or Alexa 594 conjugated-transferrin. Den-
gue infected samples were subsequently incubated with a mouse monoclonal antibody directed against dengue E protein and an 
Alexa 594 conjugated chicken anti-mouse IgG antibody. Signal from Alexa 594 (red) and GFP (green) were observed under a 
fluorescent microscope. Merged images are shown.Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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and results analyzed by agarose gel electrophoresis. Exper-
iments were undertaken independently in triplicate.
Results showed a constant signal for GAPDH and the
clathrin heavy chain (CHC) for mock and siGFP transfec-
tion (Figure 6). Message for clathrin heavy chain was seen
to be significantly reduced for all transfections, with the
greatest signal reduction being seen on day 3 post infec-
tion and for siCHC3 and siCHC5 (Figure 6).
Dengue virus serotype 2 infection of clathrin heavy chain 
silenced HepG2 cells
Optimal silencing of clathrin heavy chain expression was
noted at day 3 post transfection with siRNA constructs
siCHC3 and siCHC5. These two siRNAs were again trans-
fected into HepG2 cells as above in parallel with transfec-
tions of siGFP and mock (transfection agent only) and on
day 3 post transfection cells were infected with dengue
virus serotype 2 and an MOI of 20 and cells allowed to
grow for 15 hours (the time for one replication cycle of
dengue serotype 2 minus two hours) under optimal con-
ditions. At 15 hours cells were either analyzed by micros-
copy or by our adaptation of the standard plaque assay
[15] to determine the number of infected cells. Both
microscopy and determination of infected cell number
were undertaken independently in triplicate.
Consistent with our results with transfections of domi-
nant negative constructs of Eps15, a significant reduction
of transferrin entry was seen with siCHC transfections, but
not with mock or siGFP (Figure 7). Dengue virus serotype
2 entry was observed for mock and siGFP transfections
(Figure 7). While transfections of siCHC constructs again
reduced dengue virus entry significantly, entry of the virus
was still observed. Levels of entry of the dengue virus sero-
type 2 in siCHC transfected cells was again observed to be
on the order of 15 to 20% of cells as determined by count-
ing multiple microscope fields (n > 30).
Results of dengue virus entry as seen by our adaptation of
the standard plaque assay [15] were consistent with the
results observed by microscopy. We observed a slight
reduction of dengue virus entry in siGFP transfected cells
as compared to wild type (mock transfected) suggesting
that transfection of even irrelevant siRNAs may marginally
affect the viability of the HepG2 cells. A significant reduc-
tion in the number of dengue virus infected cells was
observed with the siCHC transfections (Figure 8, Panel A),
with the number of infected cells again being some 20%
of wild type (mock transfected) cells.
Entry of the dengue virus in the presence of dominant negative mutants of Eps15 Figure 5
Entry of the dengue virus in the presence of dominant negative mutants of Eps15. Examples of cells positive for 
both dominant negative mutants of Eps15 (DIII or EH29)-GFP (green) and dengue virus infection (red). Merged images are 
shown.Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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Silencing of Clathrin heavy chain in HepG2 cells Figure 6
Silencing of Clathrin heavy chain in HepG2 cells. Multiplex RT-PCR products for GAPDH or clathrin heavy chain (CHC) 
of HepG2 cells either mock transfected (A); transfected with siGFP (B); transfected with siCHC3 (C) or transfected with 
siCHC5 (D). Samples represent day 1 to 4 post transfection and transfections were undertaken independently in triplicate.Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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Simultaneous inhibition of macropinocytosis and clathrin 
Dengue serotype 2 infection of siRNA silenced HepG2 cells Figure 7
Dengue serotype 2 infection of siRNA silenced HepG2 cells. Indirect immunoflourescence of HepG2 cells either mock 
transfected or transfected with siGFP, siCHC3 or siCHC5 and subsequently either infected with the dengue virus (red) or 
incubated with transferrin (red). Cells were additionally stained with DAPI (blue) to show nuclei. Merged images are shown.Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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dependent endocytosis
To determine whether the approximately 20% virus entry
seen in cells in which clathrin mediated endocytosis has
been inhibited is a result of background, or the result of
dengue virus entry by macropinocytosis, we sought to
simultaneously inhibit both pathways, clathrin mediated
endocytosis through siRNA mediated RNA inhibition and
macropinocytosis through biochemical inhibition using
wortmannin.
Cells were therefore transfected with siCHC5 to silence
clathrin heavy chain or mock transfected and on day 3
post-transfection were either treated or not treated with
wortmannin for 1 hour before being either incubated with
transferrin or infected with dengue serotype 2 at an MOI
of 20. Following acid glycine treatment of dengue infected
cells, cells were incubated for 15 hours before being either
examined by microscopy or the number of infected cells
determined by our adaptation of the standard plaque
assay [15]. Experiments were all undertaken independ-
ently in triplicate.
Results (Figure 9) show that transfection with siCHC5,
but not treatment with wortmannin significantly
excluded transferrin and a similar level of transferrin
exclusion was seen between cells treated with siCHC5
alone and cells treated with siCHC5 and wortmannin in
combination. HepG2 cells treated with either siCHC5 or
wortmannin both showed a reduction in levels of dengue
infected cells as compared to control, but a significant
number of dengue infected cells was observed in each
case. The combination of siCHC5 and wortmannin treat-
ment resulted in the infection of rare, single scattered cells
(Figure 8, Panel B).
Results from our adaptation of the plaque assay (Figure 7,
Panel B) provided consistent data, with a significant
reduction in the number of dengue serotype infected cells
seen in the cells treated with a combination of siCHC5
transfection and wortmannin as compared to the siCHC5
transfected cells alone.
Discussion
Despite flaviviral infections representing a significant
world wide public health threat, little advance has been
made in dissecting out the mechanism by which flavivi-
ruses enter into either mammalian or insect cells. Studies
on Japanese encephalitis virus and West Nile virus with
either Vero (African Green monkey cells) or C6/36 cells
have suggested that these two viruses enter by clathrin
coated pit mediated endocytosis [8-10]. With the dengue
virus however, data to date, which has been predomi-
nantly generated through electron microscopy studies [4-
6], has suggested that direct fusion with the plasma mem-
brane is the standard mode of entry of the dengue viruses.
Recently Chu et al., [9] provided evidence that West Nile
virus enters into Vero cells via clathrin mediated endocy-
Infection of siRNA silenced HepG2 cells Figure 8
Infection of siRNA silenced HepG2 cells. A. HepG2 cells either mock transfected (mock) or transfected with siGFP, 
siCHC3 or siCHC5 were infected with dengue virus serotype 2 at MOI 20 and the number of infected cells determined by our 
adaptation of the standard plaque assay [15]. Results are expressed as a percentage of mock infection and error bars represent 
the SEM of three independent experiments assayed in duplicate. B. HepG2 cells were either mock transfected or transfected 
with siCHC5 and either treated or not treated with wortmannin prior to infection with the dengue virus serotype 2 at MOI 
20. Results are expressed as a percentage of mock infection and error bars represent the SEM of three independent experi-
ments assayed in duplicate.Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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Simultaneous inhibition of macropinocytosis and clathrin mediated endocytosis in HepG2 cells and infection with dengue virus  serotype 2 Figure 9
Simultaneous inhibition of macropinocytosis and clathrin mediated endocytosis in HepG2 cells and infection 
with dengue virus serotype 2. Indirect immunoflourescence of HepG2 cells either mock transfected or transfected with 
siCHC5 and subsequently either treated or not treated with wortmannin prior to infection with the dengue virus (red) at MOI 
20 or incubated with transferrin (red). Cells were additionally stained with DAPI (blue) to show nuclei. Merged images are 
shown.Journal of Biomedical Science 2009, 16:17 http://www.jbiomedsci.com/content/16/1/17
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tosis [9]. The authors however noted that pre-treatment of
Vero cells with cytochalasin D (an inhibitor of macropi-
nocytosis) resulted in an inhibition of infection and the
authors proposed that this was possibly due to an effect
upon virus trafficking due to cytochalasin D mediated de-
polymerization of actin filaments [9]. In light of the
results seen here it is possible that West Nile virus also
enters via multiple pathways and the reduction seen in
West Nile virus entry in the presence of cytochalasin D is
a consequence of ablation of the macropinocytosis path-
way rather than a consequence of altering virus trafficking.
Further support for this is seen that reduction of West Nile
virus entry in the presence of an Eps15 dominant negative
mutant is some 80%, giving some 20% virus entry in the
presence of the dominant negative mutant [9] – a figure
comparable with the data presented here for the dengue
virus.
Interestingly Chu and colleagues also investigated the
entry of West Nile Virus into the aedes albopictus cell line
C6/36 using the same dominant negative mutant of
Eps15 [8] and similarly saw 15 to 20% entry of the virus
in the presence of the mutant suggesting that West Nile
virus may similarly enter into cells of both an insect and a
mammalian origin by multiple pathways.
More recently Krishnan and colleagues have investigated
the entry of the dengue virus into HeLa cells [7]. This
study also used dominant negative mutants of Eps15 to
ablate clathrin mediated endocytosis, and similarly con-
cluded that the dengue virus entered by clathrin coated pit
mediated endocytosis. Similar to Chu and Ng [9] how-
ever, some 20% virus entry as compared to wild type lev-
els was observed, again giving the possibility that alternate
pathways are responsible for the entry of some dengue
virus into cells, and indeed, all four studies, this study and
those of Chu and Ng [9], Chu and colleagues [8] and
Krishnan and colleagues [7] suggest that ablation of clath-
rin coated pit mediated endocytosis only reduces virus
entry by 80%.
Our data suggests that the remaining 20% virus entry
observed is not the results of incomplete ablation of clath-
rin mediated endocytosis but represents virus entry by a
viable, independent pathway, macropinocytosis. Entry of
the dengue viruses (and more possibly flaviviruses in gen-
eral) by multiple pathways as shown here raises some
interesting questions, particularly with respect to the ini-
tial flavivirus: host cell interaction and may require a sig-
nificant re-evaluation of our understanding of flavivirus
entry into host cells.
Conclusion
Consistently, inhibition of clathrin mediated endocytosis
using dominant negative mutants of Eps 15 results in a
reduction of dengue virus entry of approximately 80% as
shown by this study and others [7-9]. Our data shows that
the incomplete ablation of virus entry is not a result of
incomplete knock down of clathrin mediated endocyto-
sis, but rather reflects entry via an alternate pathway.
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